Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01660503 · ClinicalTrials.gov registry record · NA
Dose Effects of SCF on Calcium Metabolism and GI Microflora in Adolescents
A NA study, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01660503: Completed NA study, sponsored by Purdue University.
NCT01660503 is a NA study that has completed, run by Purdue University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01660503, a NA study, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Soluble corn fiber (SCF) has been shown to enhance calcium utilization and bone properties in rats and in adolescent boys and girls.
Primary Outcome
The subject will be asked to consume one snack item in the morning and one snack in the evening for four consecutive weeks. After consuming the SCF product for four weeks the teen will come to Purdue University campus for 3 nights and days (e.g. Thursday noon - Sunday noon). They will reside in university residence hall or hotel near campus. Calcium Absorption testing will be done utilizing 43Ca and 44Ca.
Interventions
- DIETARY_SUPPLEMENT 0 grams SCF
- DIETARY_SUPPLEMENT 10 grams SCF
- DIETARY_SUPPLEMENT 20 grams SCF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2012-06-01 |
| Est. Completion | 2014-04-30 |
| Phase | NA |
What the finished NCT01660503 record still lists
NCT01660503 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which 0 grams SCF is the first listed.
NCT01660503 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01660503 about?
NCT01660503 is a clinical study titled "Dose Effects of SCF on Calcium Metabolism and GI Microflora in Adolescents". Soluble corn fiber (SCF) has been shown to enhance calcium utilization and bone properties in rats and in adolescent boys and girls.
What is the current status of trial NCT01660503?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2012-06-01. Estimated completion is 2014-04-30.
What interventions are being tested in trial NCT01660503?
The interventions under investigation include: 0 grams SCF (DIETARY_SUPPLEMENT), 10 grams SCF (DIETARY_SUPPLEMENT), 20 grams SCF (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01660503?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01660503's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI